G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillPodcast
![]() |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
News
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber August 01, 2008 | Press Release
Biotech remains upbeat in wake of market turmoil July 01, 2008 | Press Release
Genetic test industry faces tough challenges with consumers, survey finds June 17, 2008 | Press Release
See all NewsBurrill Canadian Biotech Weekly News
The Burrill Canadian Biotech News is a premier weekly biotechnology publication, which has been reporting on the Canadian biotech industry for over 17 years. It is the publication of record for news, events and the capital markets in Canada’s growing biotech and life sciences sectors. Its continuing commitment to an outstanding level of excellence is fueled by founder and Editor-in-Chief, Peter Winter - a bioscientist and award-winning journalist with over 25 years experience of consulting, writing and editing. He is Canada's leading expert and commentator on Canadian biotechnology and his opinions, reports and commentaries are widely sought by government organizations and companies.
A one-year subscription to Canadian Biotech News is US$775.00. Published 46 times per year (double issues in August and December), each issue brings you the latest news and analysis on Canada’s rapidly evolving public and private companies and organizations. Your paid subscription comes with a free copy of Biotech 2008: Life Sciences: A 20/20 Vision to 2020 (a $430 value)
Click here to subscribe to the Canadian Biotech News.
Add to cart$775.00

.jpg)
.jpg)